Delivery Order SPE2DB25D3003-SPE2DB25FPXAM
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cipro 500 mg tablets (100 count) at a ceiling value of $1,567.80. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a $4,510.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Cipro 500 mg tablets in quantities of 100 units. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract is scheduled for ultimate completion on September 5, 2025,...
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cipro 500 mg tablets (100-count units) with a ceiling value of $1,175.85. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside procurement issued to the prime contractor at its Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cipro 500 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,384.50, represents a non-competitive set-aside and is scheduled for completion by August 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count) valued at $2,362.87 under a firm fixed price contract. The award was made on May 27, 2025, with an ultimate completion date of May 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,175.85 to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXAMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count packages) under a firm fixed-price contract with a ceiling value of $2,351.70. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The Cipro antibiotic delivery fulfills routine pharmaceutical procurement needs within this expansive framework that enables flexible sourcing of brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to support worldwide military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/27/25 |